---
layout: post
title: "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal of Proposed Rule"
date: 2026-02-05 19:00:30 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-18729
original_published: 2022-08-29 00:00:00 +0000
significance: 8.00
---

# Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal of Proposed Rule

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** August 29, 2022 00:00 UTC
**Document Number:** 2022-18729

## Summary

The Drug Enforcement Administration (DEA) is withdrawing a proposed rule that was published in the Federal Register on April 11, 2022, which proposed to place two phenethylamine hallucinogens in schedule I of the Controlled Substances Act. DEA is withdrawing the proposed rule, terminating all proceedings related thereto, and will be publishing a new proposed rule using an amended procedure.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/08/29/2022-18729/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-iodoamphetamine-doi-and)
- API: https://www.federalregister.gov/api/v1/documents/2022-18729

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
